Telitacicept treatment for recurrent IgA nephropathy after kidney transplantation
Telitacicept shows promising safety and efficacy in lowering proteinuria for patients with recurrent IgAN following kidney transplantation.
Authors
- Yifu Hou
- Guisen Li (ORCID: https://orcid.org/0000-0003-1970-9979)
- Fang Wang (ORCID: https://orcid.org/0000-0002-5971-2622)
- Shukun Wu
- Wenjia Di
- Ping Zhang (ORCID: https://orcid.org/0000-0002-8330-2164)
- Shan Zhong (ORCID: https://orcid.org/0009-0007-0802-0902)
- Hongji Yang (ORCID: https://orcid.org/0000-0001-6561-3631)
- Lichen Xu (ORCID: https://orcid.org/0000-0002-4271-5149)
Institutions
- University of Electronic Science and Technology of China (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1093/ckj/sfaf232
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 4.29
Funders
- National Natural Science Foundation of China